neurofibromatosis glutathione type 1 The Role of Mutations on

Nash, A

Injectable Medications: GLP-1 Receptor Agonists and Amylin Analogs In addition to insulin therapy, certain injectable medications may be used as adjunct therapies to improve blood sugar control in individuals with Type 1 Diabetes: GLP-1 Receptor Agonists Glucagon-like peptide-1 (GLP-1) receptor agonists, such as liraglutide (Victoza) and exenatide (Byetta, Bydureon), stimulate insulin secretion, inhibit glucagon release, and delay gastric emptying, resulting in lower blood sugar levels

Engage consistently at industry events and conferences

PLoS One A novel small molecule screening assay using normal human chondrocytes toward osteoarthritis drug discovery